Pfizer has requested Well being Canada to approve the primary COVID-19 vaccine for youngsters aged 5 to 11 years previous.
As quickly because the regulator provides the inexperienced gentle, suppliers will have the ability to begin providing the COVID-19 shot to children, although new child-sized doses would possibly should be procured.
Learn extra:
‘Parents are asking all the right questions,’ as COVID-19 vaccine for kids awaits approval: expert
The doses are about one-third the dimensions given to adults and youths age 12 and up.
The vaccine was developed in partnership with Germany’s BioNTech and is now marketed underneath the model identify Comirnaty. It was licensed for folks not less than 16 years previous final December, and for teenagers between 12 and 15 in Could.
Pfizer already submitted scientific trial information for its child-sized dose to Well being Canada at the start of the month, and made a proper request for approval to the U.S. Meals and Drug Administration final week.
The Pfizer-BioNTech vaccine has additionally been examined on youngsters as younger as six months previous. Topline information for youngsters underneath 5 years previous is anticipated as quickly as the top of the 12 months.
Extra coming.
© 2021 The Canadian Press
https://globalnews.ca/information/8275039/pfizer-covid-vaccine-canada-kids-5-to-11/ | Pfizer asks Well being Canada to approve COVID-19 vaccines for youngsters aged 5-11 – Nationwide